Taken together, these data suggest that a distinct subpopulation of tumor cells, preferentially in an ER+ DIC with a DCIS component, undergoes EMT, invades the desmoplastic stroma, and simultaneously acquires apoptotic resistance through Bcl-xL-expression. Here, BCL2L1 is linked to ductal breast carcinoma in situ.